In its latest disclosure, Inventurus Knowledge Solutions Limited announced the formal execution of several agreements related to its previously announced acquisition of TruBridge, Inc.. These documents, dated July 3, 2026, include a facilities agreement involving various international lenders such as Citibank, Deutsche Bank, and JPMorgan Chase Bank, as well as a security agreement and power of attorney to manage the financing facilities. The company confirmed that it will maintain effective oversight of its subsidiary, IKS Inc., which is the direct borrower for these facilities.

The acquisition of TruBridge, a Nasdaq-listed healthcare technology firm, is valued at approximately $565 million and represents the company’s largest acquisition to date. This strategic move is designed to integrate TruBridge’s electronic health record (EHR) systems with IKS Health’s existing AI-driven care-enablement solutions, specifically targeting the rural and community hospital market in the United States. The transaction is being funded primarily through new debt, with the company aiming to complete the acquisition within 180 days.

Inventurus Knowledge Solutions Limited (IKS Health) is a prominent healthcare technology company that utilizes an “AI + Human” model to provide revenue cycle management (RCM), clinical documentation, and administrative support services to global health systems. Recently, the company has been active in expanding its portfolio, including the acquisition of Arai Solutions to enhance its AI research capabilities. The company is widely recognized for its scalability and has been awarded for its use of AI in healthcare, maintaining partnerships with top-tier U.S. health systems.

For the fiscal year 2026, the company reported a robust performance with revenue of ₹31,938 million, reflecting a 20% year-on-year growth, and a Profit After Tax (PAT) of ₹7,216 million, marking a 48% increase. In the fourth quarter of FY26, revenue stood at ₹858 crore, up 18.5% year-on-year, while PAT reached ₹206 crore, a 39.4% increase from the previous year. The company is notable for its strong backing by the Jhunjhunwala family, who maintain significant holdings through various trusts.